The expression of the TREM2 gene, whose product is thought to be protective in Alzheimer’s disease through promotion of amyloid clearance [69], was down-regulated in SIVE-Meth 3.3-fold, whereas TREM1 gene expression was increased 2.1-fold. This evidence concerns the gene TREM1 and early-onset autosomal dominant Alzheimer disease.